GABELLI FUNDS LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$550,890
-15.6%
750,0000.0%0.00%
-20.0%
Q4 2022$652,410
-1.7%
750,0000.0%0.01%0.0%
Q3 2022$664,000
+2.8%
750,0000.0%0.01%0.0%
Q2 2022$646,000
-2.7%
750,0000.0%0.01%
+25.0%
Q1 2022$664,000
-3.3%
750,0000.0%0.00%0.0%
Q4 2021$687,000
+3.8%
750,0000.0%0.00%0.0%
Q3 2021$662,000
-1.2%
750,0000.0%0.00%0.0%
Q2 2021$670,000
-0.3%
750,0000.0%0.00%
-20.0%
Q1 2021$672,000
+3.2%
750,0000.0%0.01%0.0%
Q4 2020$651,000
+5.3%
750,0000.0%0.01%0.0%
Q3 2020$618,000
+2.0%
750,0000.0%0.01%0.0%
Q2 2020$606,000
+22.9%
750,0000.0%0.01%
+25.0%
Q1 2020$493,000
-8.0%
750,0000.0%0.00%
+33.3%
Q4 2019$536,000
-79.6%
750,000
-80.0%
0.00%
-82.4%
Q3 2019$2,629,000
-18.8%
3,750,000
-21.1%
0.02%
-19.0%
Q2 2019$3,238,0004,750,0000.02%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$23,311,0005.66%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 44,492,000$39,153,0001.56%
UBS OCONNOR LLC 26,000,000$23,448,000,0000.34%
Saltoro Capital, LP 750,000$678,0000.17%
AQR Arbitrage LLC 3,050,000$2,758,0000.10%
WATER ISLAND CAPITAL LLC 1,500,000$1,371,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 3,448,000$3,103,0000.07%
OAKTREE CAPITAL MANAGEMENT LP 5,780,000$5,227,0000.07%
Teton Advisors, Inc. 400,000$358,0000.05%
MACQUARIE GROUP LTD 8,175,000$7,393,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders